organization · Reporting owner
Tuesday Thirteen Inc.
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Esperion Therapeutics, Inc.ESPR · Entity 30796 | 10% owner | October 26, 2018 | October 30, 2018 |
| Mirati Therapeutics, Inc.MRTX · Entity 94908 | 10% owner | September 21, 2017 | November 22, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Esperion Therapeutics, Inc.
Report date October 26, 2018 · Filed October 30, 2018
Jointly reported with Braslyn Ltd., Boxer Asset Management Inc., LEWIS JOSEPH, Boxer Capital, LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,401,000 |
Reported balance
Holding disclosure · report date 2018-10-26 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 1,401,000 F1: These securities are owned directly by Braslyn Ltd. ("Braslyn"), which may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC ("Boxer Capital"), (iii) Boxer Asset Management Inc. ("Boxer Management"), (iv) Tuesday Thirteen Inc. ("Tuesday Thirteen") and (v) Joseph C. Lewis (collectively, the "Boxer Group"), and indirectly by Joseph C. Lewis. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it does not have a pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | Direct | 1,201,250 |
Reported balance
Holding disclosure · report date 2018-10-26 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,201,250 F2: These securities are owned directly by Boxer Capital and indirectly by Boxer Management and Joseph C. Lewis. |
| Common StockSEC Table I · non-derivative | Direct | 100 |
Reported balance
Holding disclosure · report date 2018-10-26 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 100 F3: These securities are owned directly by Tuesday Thirteen and indirectly by Joseph C. Lewis. |
| Call OptionSEC Table II · derivative / convertible security · Conversion / exercise price $50.00 · Expires 2019-03-15 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2018-10-26 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance Not disclosed F2: These securities are owned directly by Boxer Capital and indirectly by Boxer Management and Joseph C. Lewis. |
| Call OptionSEC Table II · derivative / convertible security · Conversion / exercise price $60.00 · Expires 2019-03-15 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2018-10-26 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance Not disclosed F2: These securities are owned directly by Boxer Capital and indirectly by Boxer Management and Joseph C. Lewis. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities are owned directly by Braslyn Ltd. ("Braslyn"), which may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC ("Boxer Capital"), (iii) Boxer Asset Management Inc. ("Boxer Management"), (iv) Tuesday Thirteen Inc. ("Tuesday Thirteen") and (v) Joseph C. Lewis (collectively, the "Boxer Group"), and indirectly by Joseph C. Lewis. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it does not have a pecuniary interest therein.
F2: These securities are owned directly by Boxer Capital and indirectly by Boxer Management and Joseph C. Lewis.
F3: These securities are owned directly by Tuesday Thirteen and indirectly by Joseph C. Lewis.
Mirati Therapeutics, Inc.
Report date September 21, 2017 · Filed November 22, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-09-21 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2017-09-21 · Sale · Disposed 1,000 · Balance 0 F1: These securities are owned directly by the reporting person, who may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, LLC ("Boxer Capital"), (ii) Boxer Asset Management Inc. ("Boxer Management"), (iii) MVA Investors, LLC, (iv) Braslyn Ltd., (v) the reporting person, (vi) Joseph C. Lewis, (vii) Christopher Fuglesang, (viii) Rodney W. Lappe, (ix) Ivan M. Lieberburg, (x) Aaron I. Davis, (xi) Neil Reisman and (xii) Shehan B. Dissanayake. Joseph C. Lewis is the sole indirect beneficial owner of and controls Tuesday Thirteen Inc. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities are owned directly by the reporting person, who may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, LLC ("Boxer Capital"), (ii) Boxer Asset Management Inc. ("Boxer Management"), (iii) MVA Investors, LLC, (iv) Braslyn Ltd., (v) the reporting person, (vi) Joseph C. Lewis, (vii) Christopher Fuglesang, (viii) Rodney W. Lappe, (ix) Ivan M. Lieberburg, (x) Aaron I. Davis, (xi) Neil Reisman and (xii) Shehan B. Dissanayake. Joseph C. Lewis is the sole indirect beneficial owner of and controls Tuesday Thirteen Inc.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 21, 2017 Filed Nov 22, 2017 17:02 UTC | Mirati Therapeutics, Inc. MRTX · Entity 94908 | SaleCommon Stock | 1,000 | $10.65 | $10,650.00 |
DisclosureSEC source: 0000899243-17-027319 · doc4.xml · nonDerivative · entry 1 Tuesday Thirteen Inc. · CIK 0001723227 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · ownership.direct: These securities are owned directly by the reporting person, who may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, LLC ("Boxer Capital"), (ii) Boxer Asset Management Inc. ("Boxer Management"), (iii) MVA Investors, LLC, (iv) Braslyn Ltd., (v) the reporting person, (vi) Joseph C. Lewis, (vii) Christopher Fuglesang, (viii) Rodney W. Lappe, (ix) Ivan M. Lieberburg, (x) Aaron I. Davis, (xi) Neil Reisman and (xii) Shehan B. Dissanayake. Joseph C. Lewis is the sole indirect beneficial owner of and controls Tuesday Thirteen Inc. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.